Biocon Sdn. Bhd.
Biocon, one of the top Asian biopharmaceutical companies, entered Malaysia in 2010. It has set up Asia’s largest integrated insulin manufacturing facility at an investment of over US$325 million, whichis the highest foreign investment in Malaysia’s biotech industry to date. This is Biocon’s first overseas biopharmaceuticals manufacturing and research facility. Biocon’s facility in Johor recently became the first and only biopharmaceutical sterile injectablefacility to receive USFDA approval across Malaysia.